von Metzler A
J Cancer Res Clin Oncol. 1979 Sep;95(1):11-8. doi: 10.1007/BF00411104.
Piracetam and Pyrithioxin, drugs affecting the central nervous system, prolonged survival times in rats with the 3-MC sarcoma. Tumor remissions were observed in several male animals. We were able to achieve a high survival rate without metastasis after surgical removal of the tumors. The remission rate could be increased 6-fold when Piracetam was combined with Cyclophosphamid. In this group male and female animals reacted in the same manner. When used prophylactically, Piracetam proved to be more effective than Pyrithioxin. The effectiveness of Piracetam depended on the onset of treatment. Tumor remission was significant 28 weeks following 3-MC injection when 3-MC and Piracetam were given simultaneously. A remarkable increase of the tumor rate ensued when medication was discontinued. The tumor rate decreased to less than 50% 36 weeks following 3-MC injection if treatment was started 8 weeks following 3-MC application. The latter applied only to Piracetam and not to Pyrithioxin. In the EEG of rats the diminished amplitude induced by 3-MC could be fully compensated by 100 mg/kg Piracetam. All animals treated in this manner for 7 months remained tumor-free.
吡拉西坦和脑复新这两种影响中枢神经系统的药物,可延长患有3 - 甲基胆蒽肉瘤大鼠的存活时间。在几只雄性动物身上观察到肿瘤缓解情况。我们在手术切除肿瘤后能够实现无转移的高存活率。当吡拉西坦与环磷酰胺联合使用时,缓解率可提高6倍。在该组中,雄性和雌性动物反应相同。预防性使用时,吡拉西坦被证明比脑复新更有效。吡拉西坦的有效性取决于治疗开始的时间。当3 - 甲基胆蒽和吡拉西坦同时给药时,在注射3 - 甲基胆蒽28周后肿瘤缓解显著。停药后肿瘤发生率显著增加。如果在注射3 - 甲基胆蒽8周后开始治疗,在注射3 - 甲基胆蒽36周后肿瘤发生率降至50%以下。后者仅适用于吡拉西坦,而不适用于脑复新。在大鼠脑电图中,3 - 甲基胆蒽诱导的振幅降低可被100mg/kg吡拉西坦完全补偿。以这种方式治疗7个月的所有动物均无肿瘤。